Skip to main content

Closed

NEUP: Neuphoria Therapeutics Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

4thpctl

Volume

0.19×avg

Market Cap

20.97MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Neuphoria Therapeutics Inc.

NEUPNASDAQ Global Market·USD·Closed

Neuphoria Therapeutics Inc.

NEUPNASDAQ·USD·Closed

$3.88

−1.02%

$3.88

−$0.04 (1.02%)

52W Range

4thpctl

Volume

0.19×avg

Mkt Cap

20.97MUSD

P/E

-0.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings